Leerink on Laboratory Corporation of America (LH): 'Sell-off Unwarranted'

Go back to Leerink on Laboratory Corporation of America (LH): 'Sell-off Unwarranted'

Labcorp Announces 2025 Third Quarter Results

October 28, 2025 6:50 AM EDT

Updates Full-Year Guidance

Financial results from Operations for third quarter 2025 versus third quarter 2024:Revenue: $3.56 billion versus $3.28 billionDiluted EPS: $3.12 versus $2.00Adjusted EPS: $4.18 versus $3.50 Updated Full-Year Enterprise Revenue, Adjusted EPS and Free Cash Flow guidance:Revenue guidance of 7.4% to 8.0%; midpoint lowered 40 bps due to currency and acquisition timingAdjusted EPS range of $16.15 to $16.50; midpoint raised by $0.05Free Cash Flow range of $1.17 billion to $1.29 billion; midpoint raised by $25 million Signed... More